Patients come first at StrideBio.
At StrideBio, we aim to use our innovative technology and manufacturing capabilities to address the unmet needs of patients with severe inherited disorders.
The needs of the patient are central to decision-making at StrideBio and are incorporated into everything we do. We believe that patients and their families are experts in their disease and we engage patients at every phase of discovery and development. We want to understand what benefits are meaningful to patients and strive to incorporate these insights into our clinical programs.
At StrideBio, we foster partnerships with patients and advocacy communities while valuing their independence. We hold ourselves to the highest ethical standards of drug development and engage as partners to advance the science of the diseases we work on.
Find out more about our patient engagement and advocacy efforts by contacting [email protected].